Aarhus University Seal / Aarhus Universitets segl

Risks and value creation in drug development - why should I care?

Jesper Haaning, Project Vice President, Novo Nordisk   The presentation will cover Jesper’s thoughts regarding innovation in academia and how this could fit into the world of risk management, probability of success and net present value calculations in the corporate world.

10.10.2016 | Lisbeth Heilesen

Dato fre 09 dec
Tid 10:15 11:00
Sted iNANO auditorium (1593-012)

Jesper Haaning has an MSc in Biology and Ph.D. in Protein Chemistry at Aarhus University. Since 2011 he has been employed as project vice president at Novo Nordisk, where he is responsible for the clinical development of pharmaceuticals for treatment of hemophiliacs